Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

被引:0
|
作者
Caroline Cohen
Ghislaine Perrault
Guy Griebel
Philippe Soubrié
机构
[1] Sanofi-synthelabo Recherche,
来源
Neuropsychopharmacology | 2005年 / 30卷
关键词
nicotine-seeking behavior; conditioned stimuli; cannabinoid antagonist;
D O I
暂无
中图分类号
学科分类号
摘要
Conditioned stimuli are important for nicotine dependence and may trigger craving and relapse after prolonged nicotine abstinence. However, little is known about the pharmacology of this process. Among the systems that have been shown to play a role in drug-seeking behavior is the endocannabinoid transmission. Therefore, the present study examined the resistance to extinction of drug-seeking behavior elicited by nicotine-associated environmental stimuli and the effects of the selective CB1 cannabinoid antagonist rimonabant (SR141716) on the reinforcing effects of nicotine-related stimuli. Rats were trained to self-administer nicotine (0.03 mg/kg/injection, i.v.) under conditions in which responding was reinforced jointly by response-contingent nicotine injections and stimuli (light and tone). After self-administration acquisition, nicotine was withdrawn and lever pressing was only reinforced by contingent presentation of the audiovisual stimuli. Under such a condition, responding persisted for 3 months, following which nonpresentation of the cues produced a progressive extinction of responding. As expected, rats trained to lever-press for saline injections paired with the audiovisual stimuli did not acquire the self-administration. These findings indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers. When administered 1 month following nicotine withdrawal, rimonabant (1 mg/kg, i.p.) decreased conditioned behavior. These results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers. Rimonabant, which has been shown previously to reduce nicotine self-administration, may be effective not only as an aid for smoking cessation but also in the maintenance of abstinence.
引用
收藏
页码:145 / 155
页数:10
相关论文
共 32 条
  • [21] Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats
    Forget, Benoit
    Guranda, Mihail
    Gamaleddin, Islam
    Goldberg, Steven R.
    Le Foll, Bernard
    PSYCHOPHARMACOLOGY, 2016, 233 (10) : 1823 - 1828
  • [22] The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats
    Serrano, Antonia
    del Arco, Ignacio
    Javier Pavon, Francisco
    Macias, Manuel
    Perez-Valero, Vidal
    Rodriguez de Fonseca, Fernando
    NEUROPHARMACOLOGY, 2008, 54 (01) : 226 - 234
  • [23] Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
    Economidou, D
    Mattioli, L
    Cifani, C
    Perfumi, M
    Massi, M
    Cuomo, V
    Trabace, L
    Ciccocioppo, R
    PSYCHOPHARMACOLOGY, 2006, 183 (04) : 394 - 403
  • [24] Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
    Daina Economidou
    Laura Mattioli
    Carlo Cifani
    Marina Perfumi
    Maurizio Massi
    Vincenzo Cuomo
    Luigia Trabace
    Roberto Ciccocioppo
    Psychopharmacology, 2006, 183 : 394 - 403
  • [25] Age-dependent effects of the cannabinoid CB1 antagonist SR141716 on food intake, body weight change, and head-scratching behavior in rats
    Ward, S. J.
    Lefever, T. W.
    Walker, E. A.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S42 - S42
  • [26] Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats
    Barbara Budzyńska
    Marta Kruk
    Grażyna Biała
    Pharmacological Reports, 2009, 61 : 304 - 310
  • [27] Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats
    Budzynska, Barbara
    Kruk, Marta
    Biala, Grazyna
    PHARMACOLOGICAL REPORTS, 2009, 61 (02) : 304 - 310
  • [28] The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
    Bensaid, M
    Gary-Bobo, M
    Esclangon, A
    Maffrand, JP
    Le Fur, G
    Oury-Donat, F
    Soubrié, P
    MOLECULAR PHARMACOLOGY, 2003, 63 (04) : 908 - 914
  • [29] The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
    Gary-Bobo, M
    Elachouri, G
    Scatton, B
    Le Fur, G
    Oury-Donat, F
    Bensaid, M
    MOLECULAR PHARMACOLOGY, 2006, 69 (02) : 471 - 478
  • [30] Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT
    Amrinder S. Bhatti
    Cigdem Aydin
    Ozge Oztan
    Zhiyuan Ma
    Penny Hall
    Rui Tao
    Ceylan Isgor
    Psychopharmacology, 2009, 203 : 23 - 32